For patients with ACS, having a gradual onset of symptoms is associated with longer prehospital delay.
Study demonstrates for the first time in a randomized trial a return of vasomotion after device resorption by the use of bioresorbable scaffold technology in comparison to permanent drug-eluting stent.
A new study suggests that when evaluating nonculprit lesions in patients with STEMI with multivessel disease who have been reperfused, CMR and FFR have moderate-to-good agreement.
Remote ischemic conditioning was not linked to improved clinical outcomes at 12 months in patients with STEMI undergoing PCI.
Ticagrelor monotherapy was associated with a lower risk of clinically relevant bleeding compared with ticagrelor plus low-dose aspirin in high-risk patients following PCI.
This was the first randomized controlled trial comparing a delayed vs immediate invasive strategy in patients with transient STEMI.
Preexisting MCI is associated with a lower use of cardiac catheterization and coronary revascularization after acute myocardial infarction.
Typical symptoms of myocardial infarction are more common and have greater predictive value in women than in men.
Young adults with diabetes who experience an acute myocardial infarction tend to see significant health status improvements in the subsequent year and are not significantly worse off than patients who did not have diabetes at the time of acute MI.
Patients with acute coronary syndrome and diabetes have significantly higher rates of cardiogenic shock and lower rates of revascularization.